Validation of xMAP SARS-CoV-2 Multi-Antigen IgG assay in Nigeria

OBJECTIVE: There is a need for reliable serological assays to determine accurate estimates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence. Most single target antigen assays have shown some limitations in Africa. To assess the performance of a multi-antigen assay, we e...

Descripción completa

Detalles Bibliográficos
Autores principales: Iriemenam, Nnaemeka C., Ige, Fehintola A., Greby, Stacie M., Mpamugo, Augustine, Abubakar, Ado G., Dawurung, Ayuba B., Esiekpe, Mudiaga K., Thomas, Andrew N., Okoli, Mary U., Awala, Samuel S., Ugboaja, Blessing N., Achugbu, Chicago C., Odoh, Ifeanyichukwu, Nwatu, Felicia D., Olaleye, Temitope, Akayi, Loveth, Akinmulero, Oluwaseun O., Dattijo, Joseph, Onokevbagbe, Edewede, Okunoye, Olumide, Mba, Nwando, Agala, Ndidi P., Uwandu, Mabel, Aniedobe, Maureen, Stafford, Kristen A., Abimiku, Alash’le, Hamada, Yohhei, Swaminathan, Mahesh, Okoye, McPaul I., Steinhardt, Laura C., Audu, Rosemary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974966/
https://www.ncbi.nlm.nih.gov/pubmed/35363818
http://dx.doi.org/10.1371/journal.pone.0266184

Ejemplares similares

Ejemplares similares